Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors

Gynecologic Oncology

Volumn 132, Issue 1, 2014, Pages 50-54

  Landrum, Lisa M ^a   Nugent, Elizabeth K ^a   Zuna, Rosemary E ^a   Syzek, Elizabeth ^a   Mannel, Robert S ^a   Moore, Kathleen N ^a   Walker, Joan L ^a   McMeekin, D Scott ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Carboplatin; Chemotherapy; Paclitaxel; Radiation; Serous carcinoma; Uterine cancer

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; FAMOTIDINE; ONDANSETRON; PACLITAXEL;

ACUTE TOXICITY; ADULT; AGED; ANEMIA; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CUFF; DRUG DOSE REDUCTION; ENDOMETRIUM CANCER; FEMALE; HUMAN; HUMAN TISSUE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK FACTOR; THROMBOCYTOPENIA; VERY ELDERLY;

CARBOPLATIN; CHEMOTHERAPY; PACLITAXEL; RADIATION; SEROUS CARCINOMA; UTERINE CANCER;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CHEMORADIOTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84892797701     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.11.005     Document Type: Article

References (17)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. M. Chadha, P.J. Nanavati, P. Liu, J. Fanning, and A. Jacobs Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy Gynecol Oncol 75 1999 103 107
3. C.P. Morrow, B.N. Bundy, R.J. Kurman, W.T. Creasman, P. Heller, and H.D. Homesley et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
4. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041
5. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751
6. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhuis et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma Lancet 355 2000 1404 1411
7. C.L. Creutzberg, W.L. van Putten, C.C. Warlam-Rodenhuis, A.C. van den Bergh, K.A. De Winter, and P.C. Koper et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial J Clin Oncol 22 2004 1234 1241
8. A.N. Fader, D. Boruta, A.B. Olawaiye, and P.A. Gehrig Uterine papillary serous carcinoma: epidemiology, pathogenesis and management Curr Opin Obstet Gynecol 22 2010 21 29
9. D.M. Boruta, P.A. Gehrig, A.N. Fader, and A.B. Olawaiye Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 115 2009 142 153
10. K.M. Alektiar, V. Makker, N.R. bu-Rustum, R.A. Soslow, D.S. Chi, and R.R. Barakat et al. Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer Gynecol Oncol 112 2009 42 45
11. M.G. Kelly, D. O'Malley, P. Hui, J. McAlpine, J. Dziura, and T.J. Rutherford et al. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation Gynecol Oncol 95 2004 469 473
12. M.G. Kelly, D.M. O'malley, P. Hui, J. McAlpine, H. Yu, and T.J. Rutherford et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy Gynecol Oncol 98 2005 353 359
13. B.C. Turner, J.P. Knisely, B.M. Kacinski, B.G. Haffty, A.A. Gumbs, and K.B. Roberts et al. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy Int J Radiat Oncol Biol Phys 40 1998 77 84
14. R.A. Nout, V.T. Smit, H. Putter, I.M. Jurgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
15. S. Jolly, C. Vargas, T. Kumar, S. Weiner, D. Brabbins, and P. Chen et al. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer Gynecol Oncol 97 2005 887 892
16. T.Y. Ng, L.C. Perrin, J.L. Nicklin, R. Cheuk, and A.J. Crandon Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy Gynecol Oncol 79 2000 490 494
17. P.E. Schwartz The management of serous papillary uterine cancer Curr Opin Oncol 18 2006 494 499